LifeSci Acquisition Corporation (LSAC) Shareholders Approve Vincera Deal
by Nicholas Alan Clayton on 2020-12-22 at 5:10pm

LifeSci Acquisition Corporation (NASDAQ:LSAC) announced in an 8-K that its shareholders approved its combination with cancer drug developer Vincera Pharma at a special meeting earlier today.

The parties expect the transaction to close tomorrow, December 23. The filing did not divulge redemption figures, but LifeSci opened the morning of the vote at $19, so one would guess they were “manageable”.

All measures up for a vote passed by wide margins, but about 12.5% of shares voted against the combined company’s incentive plan.

LifeSci initially announced its combination with with Vincera September 29. Vincera is developing a preclinical bioconjugation platform targeting surface markers for solid tumors.

For a full list of measures on the ballot as well as vote tallies, click HERE.

Recent Posts
by Nicholas Alan Clayton on 2025-06-03 at 8:21am

At the SPAC of Dawn Futures remain slightly red ever since the OECD downgraded global growth forecasts in light of the ongoing tariff disputes. This impact is anticipated to be felt most strongly in the US and Japan, although the later is expected to begin a rebound in 2026. This organization does not include African...

by Nicholas Alan Clayton on 2025-06-02 at 3:57pm

Crown Reserve Acquisition Corp. I (NASDAQ:CRACU) has filed for a $150 million IPO to seek out a biotech deal with a team tied to one of the busiest names in SPACs recently. The new SPAC was filed as something of a pair with Quantumsphere Acquisition Corporation (NASDAQ:QUMSU), which was also underwritten by SPAC Advisory Partners...

by Nicholas Alan Clayton on 2025-06-02 at 12:51pm

FG Merger III Corp. has filed for a $150 million IPO to continue with the FG serial SPAC family with a larger vehicle focused on the financial services industry. The new SPAC is one of 16 SPACs that were filed in May and one of the four that overfunded its trust. FG Merger III is...

by Jonathan Perez on 2025-06-02 at 11:36am

In our May 2025 corporate actions analysis, the SPAC market highlighted dependence on deadline extensions, with all votes involving sponsors seeking their third extension or beyond. While the total number of extension-related actions declined slightly from April, activity remained elevated compared to earlier months, reflecting the continued overhang from the 2021 SPAC wave. Extension Votes...

by Nicholas Alan Clayton on 2025-06-02 at 8:25am

At the SPAC of Dawn The first week of June begins with just a pair of SPAC votes on the calendar, both of which are extensions, but this is a month that tends to host a fair amount of SPAC activity each year. Friday’s after-hours filing period may have provided a hint of this with...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved